NN2101-DM1

N/A

Report date: 2022/04/18 10:56:32

Base Information

Drug NameNN2101-DM1

Drug Alias NameNN2101-DM1NN-2101-DM-1NN-2101-DM1NN2101-DM-1

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-Stem cell growth factor receptor

TargetsStem cell growth factor receptor

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungGastrointestinal Stromal TumorsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungGastrointestinal Stromal TumorsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

ATC CodeN/A